Zephyr expands integration to financial institutions worldwide through a partnership with Digital Financial
NEW YORK, Oct. 14, 2021
NEW YORK, Oct. 14, 2021 /PRNewswire/ -- Zephyr, a subsidiary of Informa plc (LSE: INF), and a recognized leader in providing data, insight and analysis to investment professionals and financial advisors, has made it easier for their customers to fully integrate client portfolios onto the Zephyr platform regardless of where those accounts are held. Utilizing technology available through Digital Finance, a Protocol for Asset Information Exchange known as PAIXTM , the transfer of data via direct custodian feeds, held-away assets, alternative pricing, transactions, security level detail, holdings, corporate actions and historical data can be accomplished easily and accurately.
"We've removed any barriers to fully access and transfer client financial data," says Chris Volpe, Head of Informa Financial Intelligence's Zephyr business. "Investment professionals and financial advisors will now have the ability to fully and accurately report and analyze all client accounts, opening up significant opportunities for increasing their client acquisition and retention."
The Digital Financial unified DiFi model called PAIXTM automates data sourcing free from legacy IT and capital constraints with their patented data architecture, allowing users of the Zephyr platform to utilize the popular performance reporting and analysis tool, which provide returns and analysis at multiple levels of client assets including: total portfolio, asset class and asset sub class or any customized classification structure. Zephyr users may also benchmark against a large number of market Indices or custom blended benchmarks, providing a full picture of their client's accounts and supported by a team of data professionals.
"Any data driven business platform is dependent on access to robust, accurate and comprehensive data. We are excited to be partnering with Zephyr to provide best-in-class data access enabling Zephyr clients to focus on realizing the full value of a best-in-class platform for their businesses," says Carl Reed DiFi CTO.
Zephyr provides investment professionals access to timely information, exclusive research and comprehensive data to keep their clients engaged and informed. The platform consistently scores high among users for its ease of use, custom client presentation options, portfolio performance generation and ESG analysis tools. The Zephyr team is committed to ensuring their customers possess all the necessary resources to exceed their client's expectations. Visit financialintelligence.informa.com to learn more about Zephyr and to request a demo or 14-day free trial on the Zephyr platform.
New Tech Tools Designed to Help You Win Clients and Influence Investors
Join Zephyr's Director of Product Management, Randy Jones and the company's Market Strategist, Ryan Nauman and AppCrown's Growth Strategist Franklin Tsung on October 21, 2021 at 4pm EDT for an Exclusive Webinar that discusses New Tech Tools Designed to Help You Win Clients and Influence Investors. Moderated by Wealth Management's Editor-in-Chief, David Armstrong, the program focuses on trends that have financial advisors poised to acquire clients from every demographic group and how technology is driving success. To register, visit WealthManagement.com.
Zach Allegretti, JConnelly
View original content to download multimedia:https://www.prnewswire.com/news-releases/zephyr-expands-integration-to-financial-institutions-worldwide-through-a-partnership-with-digital-financial-301400334.html
PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.
- iQIYI releases 260 new titles at 2021 iJOY Conference, integrating content with technology
- St Kitts and Nevis Expands Visa-Free Travel to Palestine, Recording Fourth Diplomatic Agreement in Less Than Four Weeks
- EQS-News: Netcetera ACS ensuring secure payments with American Express Middle East
- Core One Labs Applauds the City of Seattle in Their Efforts to Decriminalize Psylocibin and Other Natural Occuring Entheogenic Drugs
- Neurocrine Biosciences to Present ONGENTYS® (opicapone) and INGREZZA® (valbenazine) Data at the American Neurological Association 2021 Virtual Annual Meeting
- Update on U.S. FDA Review of Biologics License Application (BLA) for bimekizumab